- Home
- Publications
- Publication Search
- Publication Details
Title
Successful treatment of DEAP-HUS with eculizumab
Authors
Keywords
Atypical HUS, DEAP-HUS, CFH autoantibodies, Eculizumab, Treatment algorithm
Journal
PEDIATRIC NEPHROLOGY
Volume 29, Issue 5, Pages 841-851
Publisher
Springer Nature
Online
2013-11-19
DOI
10.1007/s00467-013-2654-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined Complement Gene Mutations in Atypical Hemolytic Uremic Syndrome Influence Clinical Phenotype
- (2013) E. Bresin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Atypical HUS: time to take stock of current guidelines and outcome measures?
- (2013) Lesley Rees PEDIATRIC NEPHROLOGY
- Renal Transplantation Under Prophylactic Eculizumab in Atypical Hemolytic Uremic Syndrome With CFH/CFHR1 Hybrid Protein
- (2012) S. Krid et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Overall Neutralization of Complement Factor H by Autoantibodies in the Acute Phase of the Autoimmune Form of Atypical Hemolytic Uremic Syndrome
- (2012) C. Blanc et al. JOURNAL OF IMMUNOLOGY
- Atypical Hemolytic Uremic Syndrome-Associated Variants and Autoantibodies Impair Binding of Factor H and Factor H-Related Protein 1 to Pentraxin 3
- (2012) A. Kopp et al. JOURNAL OF IMMUNOLOGY
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- (2012) Julien Zuber et al. Nature Reviews Nephrology
- Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous Nephropathy
- (2011) J. M. Hofstra et al. Clinical Journal of the American Society of Nephrology
- Alternative Pathway Activation of Complement by Shiga Toxin Promotes Exuberant C3a Formation That Triggers Microvascular Thrombosis
- (2011) M. Morigi et al. JOURNAL OF IMMUNOLOGY
- Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome
- (2011) Stefanie Strobel et al. KIDNEY INTERNATIONAL
- Pulse Cyclophosphamide Therapy and Clinical Remission in Atypical Hemolytic Uremic Syndrome With Anti–Complement Factor H Autoantibodies
- (2010) Olivia Boyer et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD)
- (2010) Lars G. Fritsche et al. HUMAN MOLECULAR GENETICS
- Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus
- (2010) John G. Hanly et al. JOURNAL OF IMMUNOLOGICAL METHODS
- The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
- (2010) E. G. de Jorge et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Clinical Features of Anti-Factor H Autoantibody-Associated Hemolytic Uremic Syndrome
- (2010) M.-A. Dragon-Durey et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: A pediatric report and literature review
- (2010) Jérôme Harambat et al. Pediatric Critical Care Medicine
- Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation
- (2010) Samhar I. Al-Akash et al. PEDIATRIC NEPHROLOGY
- DEAP-HUS: Deficiency of CFHR plasma proteins and autoantibody-positive form of hemolytic uremic syndrome
- (2010) Peter F. Zipfel et al. PEDIATRIC NEPHROLOGY
- Efficacy of eculizumab in a patient with factor-H-associated atypical hemolytic uremic syndrome
- (2010) Anne-Laure Lapeyraque et al. PEDIATRIC NEPHROLOGY
- Plasmatherapy in Atypical Hemolytic Uremic Syndrome
- (2010) Chantal Loirat et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- The Autoimmune Disease DEAP-Hemolytic Uremic Syndrome
- (2010) Christine Skerka et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Anti-Factor H Autoantibody–Associated Hemolytic Uremic Syndrome: Review of Literature of the Autoimmune Form of HUS
- (2010) Marie-Agnès Dragon-Durey et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Efficacy of Eculizumab in the Treatment of Recurrent Atypical Hemolytic-Uremic Syndrome After Renal Transplantation
- (2010) Carlos Fernández-de Larrea et al. TRANSPLANTATION
- Maintenance of Kidney Function Following Treatment With Eculizumab and Discontinuation of Plasma Exchange After a Third Kidney Transplant for Atypical Hemolytic Uremic Syndrome Associated With a CFH Mutation
- (2009) Jean-Claude Davin et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Anti-Factor H Autoantibodies in a Fifth Renal Transplant Recipient with Atypical Hemolytic and Uremic Syndrome
- (2009) M. Le Quintrec et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation
- (2009) S. Heinen et al. BLOOD
- Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome
- (2009) I. Moore et al. BLOOD
- Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome
- (2009) C. Abarrategui-Garrido et al. BLOOD
- Eculizumab
- (2009) Eline A. Dubois et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Practice Guidelines for the management of atypical Haemolytic Uraemic Syndrome in the United Kingdom
- (2009) C. Mark Taylor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature
- (2009) Mischelle A. Elliott et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Shiga Toxin Activates Complement and Binds Factor H: Evidence for an Active Role of Complement in Hemolytic Uremic Syndrome
- (2009) Dorothea Orth et al. JOURNAL OF IMMUNOLOGY
- The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome
- (2009) M-A Dragon-Durey et al. JOURNAL OF MEDICAL GENETICS
- Functional analyses indicate a pathogenic role of factor H autoantibodies in atypical haemolytic uraemic syndrome
- (2009) S. Strobel et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Eculizumab for Atypical Hemolytic–Uremic Syndrome
- (2009) Jens Nürnberger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Eculizumab for Congenital Atypical Hemolytic–Uremic Syndrome
- (2009) Ralph A. Gruppo et al. NEW ENGLAND JOURNAL OF MEDICINE
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous Nephropathy
- (2009) Laurence H. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atypical Hemolytic–Uremic Syndrome
- (2009) Marina Noris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atypical Hemolytic Uremic Syndrome Associated With Complement Factor H Autoantibodies and CFHR1/CFHR3 Deficiency
- (2009) Beom Hee Lee et al. PEDIATRIC RESEARCH
- Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome
- (2008) T. Kwon et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome
- (2008) Gema Ariceta et al. PEDIATRIC NEPHROLOGY
- Complement and the atypical hemolytic uremic syndrome in children
- (2008) Chantal Loirat et al. PEDIATRIC NEPHROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started